answer text |
<p>The Department works with NHS Improvement, NHS England, the Medicines and Healthcare
products Regulatory Agency (MHRA), Public Health England, and the Medication Safety
Officer Network to improve the safety of medicine use across the National Health Service
in England.</p><p> </p><p>The Medication Safety Programme, covering the NHS in England,
has been established to take up the World Health Organization’s (WHO) global challenge
to reduce the incidence of severe and avoidable harm in relation to medication globally
by 50% over five years. Progress to date includes the publication of the Short Life
Working Group into Reducing Medication Harm and the publication of an evidence-based
review on the Prevalence and Economic Burden of Medication Errors in the NHS in England,
which has helped the programme to understand the scale of the issue and identify key
areas for improvement. Based on the findings of these reports, the Programme has established
four domains: patients; medicines; healthcare professionals; and systems and practice,
mirroring the WHO’s key recommendations. These domains will also focus on the three
key priorities of polypharmacy, high risk situations, and transitions of care.</p><p>
</p><p>The NHS Improvement Medicines Safety Team comprises senior pharmacists and
pharmacy technicians who provide specialist insight to support medication safety across
a range of healthcare settings in England. Their work covers several specific areas,
including the identification of potentially new, rare or under recognised or emerging
risks to patient safety related to medication; and the coordination of programmes
of work with the Department, NHS England and MHRA through the Medication Safety Programme.</p>
|
|